These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28596160)

  • 41. Urinary angiotensinogen excretion is associated with blood pressure in obese young adults.
    Sato E; Mori T; Satoh M; Fujiwara M; Nakamichi Y; Oba I; Ogawa S; Kinouchi Y; Sato H; Ito S; Hida W
    Clin Exp Hypertens; 2016; 38(2):203-8. PubMed ID: 26825581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary angiotensinogen excretion in Australian Indigenous and non-Indigenous pregnant women.
    Pringle KG; de Meaultsart CC; Sykes SD; Weatherall LJ; Keogh L; Clausen DC; Dekker GA; Smith R; Roberts CT; Rae KM; Lumbers ER
    Pregnancy Hypertens; 2018 Apr; 12():110-117. PubMed ID: 29674190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary Angiotensinogen Could Be a Prognostic Marker of Renoprotective Effects of Alogliptin in Patients with Type 2 Diabetes.
    Mizushige T; Kobori H; Nishijima Y; Yano Y; Sakata K; Hayakawa M; Nishiyama A
    J Diabetes Res; 2015; 2015():517472. PubMed ID: 26380312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors.
    Eickhoff MK; Dekkers CCJ; Kramers BJ; Laverman GD; Frimodt-Møller M; Jørgensen NR; Faber J; Danser AHJ; Gansevoort RT; Rossing P; Persson F; Heerspink HJL
    J Clin Med; 2019 May; 8(6):. PubMed ID: 31159350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Important aspects of urine sampling for angiotensinogen measurement: time and preservation conditions in healthy individuals.
    Nishijima Y; Kobori H; Sofue T; Kaifu K; Moriwaki K; Hara T; Hitomi H; Kohno M; Nishiyama A
    Tohoku J Exp Med; 2012 Dec; 228(4):333-9. PubMed ID: 23132274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary angiotensinogen is a marker for tubular injuries in patients with type 2 diabetes.
    Terami T; Wada J; Inoue K; Nakatsuka A; Ogawa D; Teshigawara S; Murakami K; Katayama A; Eguchi J; Makino H
    Int J Nephrol Renovasc Dis; 2013; 6():233-40. PubMed ID: 24174882
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet.
    Scholtes RA; Muskiet MHA; van Baar MJB; Hesp AC; Greasley PJ; Hammarstedt A; Karlsson C; Hallow KM; Danser AHJ; Heerspink HJL; van Raalte DH
    Kidney Int Rep; 2022 May; 7(5):1084-1092. PubMed ID: 35570989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA.
    Kobori H; Katsurada A; Miyata K; Ohashi N; Satou R; Saito T; Hagiwara Y; Miyashita K; Navar LG
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1257-63. PubMed ID: 18353869
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Six Kinds of Sodium-Glucose Cotransporter 2 Inhibitors on Metabolic Parameters, and Summarized Effect and Its Correlations With Baseline Data.
    Yanai H; Hakoshima M; Adachi H; Kawaguchi A; Waragai Y; Harigae T; Masui Y; Kakuta K; Hamasaki H; Katsuyama H; Kaga T; Sako A
    J Clin Med Res; 2017 Jul; 9(7):605-612. PubMed ID: 28611861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Vascular Endothelial and Diastolic Function in Heart Failure With Preserved Ejection Fraction　- Novel Prospective Cohort Study.
    Sakai T; Miura S
    Circ Rep; 2019 Jun; 1(7):286-295. PubMed ID: 33693152
    [No Abstract]   [Full Text] [Related]  

  • 51. Changes in urinary glucose concentration and body weight in patients treated with the selective SGLT2 inhibitor luseogliflozin.
    Jinnouchi H; Yoshida A; Tsuyuno H; Iwamoto K; Sugiyama S; Hieshima K; Kajiwara K; Kurinami N; Suzuki T; Jinnouchi K; Jinnouchi T
    Diabetes Res Clin Pract; 2021 Dec; 182():108916. PubMed ID: 34119556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary albumin excretion in patients with uncomplicated diffuse psoriasis.
    Utas S; Utas C; Kelestimur F; Bas K; Sahin S; Pasaoglu H; Soyuer U
    Acta Derm Venereol; 1995 Jan; 75(1):88. PubMed ID: 7747551
    [No Abstract]   [Full Text] [Related]  

  • 53. Therapeutic potential of tofogliflozin on nephrotic syndrome secondary to diabetic nephropathy.
    Tanaka A; Nakamura T; Sato E; Node K
    J Cardiol Cases; 2017 Jul; 16(1):30-33. PubMed ID: 30279791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and genetic determinants of urinary glucose excretion in patients with diabetes mellitus.
    Monobe K; Noso S; Babaya N; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Minohara T; Kawabata Y; Ikegami H
    J Diabetes Investig; 2021 May; 12(5):728-737. PubMed ID: 32986906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring.
    Torimoto K; Okada Y; Koikawa K; Tanaka Y
    Diabetol Metab Syndr; 2017; 9():60. PubMed ID: 28785316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of Luseogliflozin on Vaginal Bacterial and Fungal Populations in Japanese Patients With Type 2 Diabetes.
    Kusunoki M; Tsutsumi K; Wakazono N; Hisano F; Miyata T
    J Clin Med Res; 2021 May; 13(5):309-316. PubMed ID: 34104283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sodium
    Shah CV; Robbins TS; Sparks MA
    Kidney Med; 2022 Oct; 4(10):100533. PubMed ID: 36185705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Angiotensinogen excretion in rat urine: effects of lipopolysaccharide treatment and sodium balance.
    Yoshiya M; Tsutsui Y; Itoh N; Okamoto H
    Jpn J Pharmacol; 1991 Sep; 57(1):37-44. PubMed ID: 1800798
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal Angiotensinogen and Sodium-Glucose Cotransporter-2 Inhibition: Insights from Experimental Diabetic Kidney Disease.
    Burns KD; Cherney D
    Am J Nephrol; 2019; 49(4):328-330. PubMed ID: 30921790
    [No Abstract]   [Full Text] [Related]  

  • 60. Relationship of blood pressure to sodium excretion in a population survey.
    Simpson FO; Waal-Manning HJ; Bolli P; Phelan EL; Spears GF
    Clin Sci Mol Med Suppl; 1978 Dec; 4():373s-375s. PubMed ID: 282090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.